Drug intelligence / Profile preview

OneDose

Development stage
Preclinical
Lead developer
Crescent Innovations
Modality
Drug Delivery Systems
Administration
Oral, Topical, Subcutaneous, Intravenous, Intramuscular, Inhalation, Intranasal, Ophthalmic, Otic, Rectal, Vaginal, Sublingual, Buccal, Transdermal, Intradermal, Intrathecal, Intratumoral, Intraperitoneal, Intra-arterial, Implant
01

Overview

OneDose is a proprietary extended-release drug delivery platform developed by Crescent Innovations, specifically designed for post-surgical pain management. The technology is engineered to provide a single-dose administration that maintains drug release for approximately 24 hours, aiming to bridge the critical early post-operative period where pain management is most intensive. While the platform is a key component of Crescent Innovations' pipeline, the specific active pharmaceutical ingredients and molecular targets associated with the OneDose system have not been publicly disclosed. The development of the platform has been supported by SBIR grants, with Phase 1 complete and Phase 2 pending as of the latest reports.

Brand names
OneDose

Beyond the preview

Go deeper on OneDose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OneDose.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call